Corporate Tech Investors

Human Longevity

Human Longevity is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Human Longevity, Inc. (HLI), was founded by leaders in genomics with the ultimate goal of giving everyone access to the power of data-driven health intelligence. HLI combines state-of-the-art DNA sequencing and expert analysis with machine learning, to help change medicine to a more data-driven science. With a multidisciplinary team of research scientists, computing experts and physicians, we are empowering every part of the healthcare system to work more efficiently.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/27/2021

Transaction History

Our records indicate that Human Longevity invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

David Karow

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Human Longevity has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

HuffPost | Humana

Share this article

About Our Corporate Tech Investor Database

This corporate tech investor profile is powered by VentureDeal.com, a market leader in strategic investor transaction data for corporations that invest in the tech sector.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary